Consumer Health Neurology
Merz Therapeutics Receives TGA Approval for XEOMIN® in Australia
This marks a significant milestone as XEOMIN® is the first approved neurotoxin for the treatment of this condition in the Australian market. Addit...
November 23, 2023 | News
Fujitsu Licenses Topological Data Analysis Tech to Bay Area Startup Delight Health for Mental Health Solutions
Fujitsu Limited and Delight Health, a Bay Area startup, announced that Fujitsu will license its Topological Data Analysis (TDA) technology to Delight...
November 20, 2023 | News
Aquinnah Pharmaceuticals Advances Alzheimer's Tauopathy Program
Aquinnah Pharmaceuticals announced preclinical research findings for a novel therapeutic designed to slow or stop the progression of Alzheimer's disea...
October 31, 2023 | News
Clario's Opal® Technology Drives Breakthrough in Parkinson's Disease at University of Oxford
Clario's Precision Motion Opal® wearable sensor technology detects early Parkinson's disease (PD) progression in a Univ...
October 30, 2023 | News
PharmaKure submits for Alzheimer's Disease Combined Drug Clinical Trial
PharmaKure, a clinical stage pharmaceutical company developing precision medicines for Alzheimer’s Disease and other neurodegenerative diseases...
October 25, 2023 | News
Rimegepant Now Available in Hong Kong as First Asian Market for Migraine Management
"As the first market in Asia, we are pleased to bring to Hong Kong this medication for migraine, as we understand how migraine can adversely...
October 02, 2023 | News
Bionomics Reports Positive Phase 2b Results for BNC210 in Post-Traumatic Stress Disorder Trial
ATTUNE trial met its primary endpoint showing BNC210 treatment led to a statistically significant reduction in total PTSD symptom severity at 12 weeks. St...
September 29, 2023 | News
Cellectricon expands neuroscience contract research portfolio with new Neuroplasticity services
Cellectricon, a services provider dedicated to advancing neuroscience drug discovery, announced the launch of a new service module for neuroplasticit...
September 27, 2023 | News
Actinogen optimizes XanaMIA Phase 2b Alzheimer's disease trial design
Changes to the XanaMIA protocol reduce cost by AUD 30 million over the next two years and speed time to initial results while preserving the 36-week design...
September 27, 2023 | News
Ascletis Completes Enrollment for Glioblastoma Treatment Trial
Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces the completion of enrollment of 120 patients in the Phase III registration clinical trial of ...
September 27, 2023 | News
Cerecin strengthens position in neurometabolism with addition to pipeline
Cerecin completes in-licensing of an investigational radiolabelled tracer 18FBHB, CER-022, for development and use in positron emission tomography (...
September 20, 2023 | News
Oscotec/ADEL Receives FDA Clearance for Alzheimer's Treatment IND Application (ADEL-Y01)
Oscotec and ADEL are jointly developing a novel disease-modifying immunotherapy agent (ADEL-Y01) targeting tau protein accumulation in the AD brain. ADEL-Y...
September 15, 2023 | News
IBT and ATLATL Join Forces to Tackle Challenges in Brain Health
Starting out of China, IBT Global is a rising player in Digital Therapeutics (DTx) with an experienced cross-functional team operating at the intersection ...
September 05, 2023 | News
Salvia BioElectronics Treats First Patient with Neuromodulation for Severe Migraine in Australia
The first patient, a 29-year-old woman from Australia who has suffered from debilitating headaches since the age of 14, experienced immediate and...
August 24, 2023 | News
Most Read
- Companies Embracing Rebranding in Biotech, Life Sciences, and Biopharma
- China-Africa medical cooperation broadens under BRI
- Singapore's National University Health System Launches World's First Public Hospital Healthy Longevity Clinic
- Innovac Therapeutics Secures $18M Pre-A Funding for Lead Program Development
- Sirnaomics' STP707 Shows Promise in Phase I Solid Tumor Study
- Agilent Receives European IVDR Certification for Companion Diagnostic Assay
- BioSkryb Genomics Partners with Research Instruments: Bringing Single-Cell Tech to Singapore & Southeast Asia
- Thermo Fisher Launches 'Made in India' TSV Series Lab Refrigerators and Freezers
Bio Jobs
- Cameron Smith Appointed as Chief Business Development Officer for Agilex Biolabs
- New Survey Reveals Insights on Singapore Workers' Preparedness for Digital Transformation
- Danaher Careers - Search Global Science and Technology Jobs
- Suvoda Expands Board of Directors With Addition of Clinical Trial Veteran Irena Webster
- Careers at MERCK Group
- Ajinomoto Bio-Pharma Services Announces Leadership Changes at US Facility
- Veranova Appoints Mike Riley as Chief Executive Officer
- Find your Job at Eppendorf
News
Editor Picks
